Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,306 recruiting studies in this area right now.
By phase
- Not applicable9,599
- Phase 24,428
- Phase 12,678
- Phase 1/Phase 21,650
- Phase 31,399
- Phase 2/Phase 3286
- Phase 4266
Top conditions
- Breast Cancer1,206
- Prostate Cancer645
- Cancer638
- Colorectal Cancer481
- Lung Cancer422
- Ovarian Cancer342
- Multiple Myeloma330
- Pancreatic Cancer288
- Gastric Cancer285
- Acute Myeloid Leukemia283
- Hepatocellular Carcinoma257
- Solid Tumor245
- Advanced Solid Tumor232
- Head and Neck Cancer228
- Cervical Cancer226
- Endometrial Cancer215
- Advanced Solid Tumors206
- Esophageal Cancer191
Leading sponsors
- M.D. Anderson Cancer Center454
- Fudan University305
- National Cancer Institute (NCI)294
- Memorial Sloan Kettering Cancer Center291
- Sun Yat-sen University274
- Mayo Clinic238
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences145
- City of Hope Medical Center145
- AstraZeneca133
- Ruijin Hospital128
Where studies are running
- California1,397
- Texas631
- Arizona508
- Florida436
- Alabama429
- New York406
- Massachusetts339
- Maryland331
- New Jersey275
- Pennsylvania236
Recruiting studies20,306 total
- NCT06880523RecruitingPhase 2
Adding lenvatinib to immunotherapy for liver cancer
This trial tests adding lenvatinib (a targeted therapy pill) to a combination of two immunotherapy drugs (durvalumab and tremelimumab) for people with liver cancer that cannot be removed by surgery. The goal is to see if the three-drug approach works better than the two immunotherapy drugs alone.
Calgary, AlbertaAges 18 years+ - NCT06800989Recruiting
Can sophrology with a wearable device reduce chemo anxiety?
This study tests whether a relaxation technique called sophrology, guided by a wearable device, can help reduce anxiety during chemotherapy for early-stage breast cancer. It aims to offer extra support during treatment.
AngersAges 18 years+ - NCT06890273Recruiting
Study of durvalumab and olaparib for endometrial cancer
This study looks at how well two drugs, durvalumab and olaparib, work together after initial chemotherapy for advanced or recurrent endometrial cancer. It may help patients who have not had many treatment options before.
AmbergAges 18–130 - NCT06885424Enrolling by invitation
Long-term follow-up for A2 Bio gene therapy patients
This study follows up with people who previously received a gene therapy product from A2 Biotherapeutics in an earlier trial. The goal is to monitor their health over time and check for any long-term effects.
Gilbert, ArizonaAges 18 years+ - NCT06889883Recruiting
Blood test for early colorectal cancer detection
This study is testing a new blood test to find colorectal cancer early. You may be able to join if you are about to have a colonoscopy or surgery for a suspected tumor.
Zaragoza, AragonAges 18 years+ - NCT06883058Enrolling by invitation
CASA Program for Distressed Patients and Caregivers
This trial tests a program called CASA that helps both patients with advanced cancer and their caregivers cope with distress. If you or your loved one feel overwhelmed by worry or sadness, this support program may help you manage those feelings together.
Ponce, PRAges 21–105 - NCT06880549RecruitingPhase 1
mRNA cancer vaccines alone or with other drugs for solid tumors
This study tests two experimental mRNA vaccines (mRNA-4106 and mRNA-4200) given either alone or together with other cancer treatments. The goal is to see if they are safe and work against advanced or metastatic solid tumors like melanoma, lung, liver, and colon cancer. Participation requires that you have tried or refused all standard treatments.
Los Angeles, CaliforniaAges 18 years+ - NCT06883526RecruitingPhase 1/Phase 2
ZG005 plus gecacitinib for lymphoma that has returned or not responded
This trial tests a combination of two drugs, ZG005 and gecacitinib, for people with lymphoma that has come back or hasn't gotten better with prior treatment. The goal is to see if this combination can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18 years+ - NCT06884618RecruitingPhase 1
Study of a new drug for advanced solid tumors with RAS mutations
This trial is testing an experimental drug for people whose cancer has spread and has a specific gene change called RAS. The study aims to see if the drug is safe and helps shrink tumors.
Duarte, CaliforniaAges 18 years+ - NCT06882135RecruitingPhase 1
Testing an experimental drug for advanced solid tumors
This trial studies a new drug called HW071021 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can help shrink or control the cancer.
Guangzhou, GuangdongAges 18 years+ - NCT06885281RecruitingPhase 1/Phase 2
Study of ZL-1310 for neuroendocrine carcinoma
This trial is testing an experimental drug called ZL-1310 for people with neuroendocrine carcinoma (a rare, fast-growing cancer) that has spread or can't be removed. It aims to see if the drug is safe and works against the cancer.
San Francisco, CaliforniaAges 18 years+ - NCT06889844Recruiting
Blood test for colorectal cancer cross-reactivity study
This research study uses a blood test to look for signs of colorectal cancer in people who have other types of cancer or digestive diseases. The goal is to see if the test can correctly tell the difference between colorectal cancer and other conditions.
Málaga, AndalusiaAges 18 years+ - NCT06887348Recruiting
Long-term safety study for prior RP1, RP2, or RP3 patients
This study checks the long-term safety of patients who have already received RP1, RP2, or RP3 treatment in a previous study. It helps doctors understand any side effects that may appear over time.
La Jolla, CaliforniaAges 18 years+ - NCT06883747RecruitingEarly Phase 1
Study of BMS-986504 for recurrent brain tumor
This trial tests an experimental drug, BMS-986504, for people with recurrent glioblastoma (a type of brain cancer). The drug targets a specific genetic change in the tumor. It aims to see if the drug can help shrink or slow the tumor.
Phoenix, ArizonaAges 18 years+ - NCT06889766RecruitingPhase 1
NY-ESO-1 T cells for advanced melanoma and sarcoma
This trial tests a personalized cell therapy using your own immune cells (T cells) that have been modified to recognize a protein called NY-ESO-1, which is found on some melanoma and sarcoma tumors. It may help people whose cancer has progressed after standard treatments.
Lausanne, Canton of VaudAges 18 years+ - NCT06889688RecruitingPhase 3
New drug combo vs. chemo for advanced triple-negative breast cancer
This trial tests a new combination of three drugs (camrelizumab, apatinib, and eribulin) against the standard chemotherapy chosen by your doctor. It's for people with advanced triple-negative breast cancer that has gotten worse after previous treatments.
Guangzhou, GuangdongAges 18–70 - NCT06888830RecruitingPhase 1/Phase 2
Study of JS212 for advanced solid tumors
This trial tests a new drug called JS212 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if it is safe and if it can help shrink tumors.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06882057RecruitingPhase 2/Phase 3
Treatment for newly diagnosed low-risk pediatric B-ALL
This trial tests a treatment plan for children newly diagnosed with low-risk B-cell ALL. It aims to improve outcomes while reducing side effects.
Hefei, AnhuiAges 1–18 - NCT06889493RecruitingPhase 1
SVV-001 plus immunotherapy for neuroendocrine cancers
This trial tests a new virus-based treatment (SVV-001) combined with two immunotherapy drugs (nivolumab and ipilimumab) for people with advanced neuroendocrine cancers that have gotten worse after at least one prior treatment. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
Miami, FloridaAges 18 years+ - NCT06882486Recruiting
Kidney removal after successful immunotherapy for metastatic cancer
This trial is for people with kidney cancer that has spread to other parts of the body, who still have their original kidney tumor. If your cancer has responded very well to immunotherapy (a type of treatment that helps your immune system fight cancer), doctors want to see if removing the kidney tumor now can improve your outcome.
Marseille, Institut Paoli-calmettesAges 18 years+ - NCT06888817RecruitingPhase 3
Bevacizumab vs steroids for brain radiation injury
This trial tests if bevacizumab works better than steroids for people with brain swelling caused by radiation. If you have this condition and meet certain health requirements, you may join.
AmsterdamAges 18 years+ - NCT06885203Recruiting
Breast cancer survivorship study for Black women
This study looks at how social and environmental factors affect breast cancer survivorship in Black women. It aims to develop and test an intervention to improve outcomes, and it involves both trainers and participants.
Houston, TexasAges 18 years+ - NCT06883838Enrolling by invitation
Improving cancer survivorship care in community health centers
This study aims to improve how cancer survivorship care is delivered in community health centers. It looks at ways to better support people who have had cancer and the staff who care for them.
Houston, TexasAges 18 years+ - NCT06885879Recruiting
Studying ctDNA changes after radiation for liver cancer
This trial studies how radiation therapy (SBRT) affects a DNA fragment in the blood called ctDNA in people with liver cancer. By tracking ctDNA changes, doctors hope to better understand how well the treatment is working and possibly predict outcomes earlier.
Hong KongAges 18 years+
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,306 recruiting oncology studies from the U.S. registry right now, out of 31,256 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.